NCT06584019 is a NA clinical trial of Range Of Motion applied group in Children With Cancer, sponsored by Istanbul Medipol University Hospital.

Who is sponsoring NCT06584019?

NCT06584019 is sponsored by Istanbul Medipol University Hospital.

What drugs are being tested in NCT06584019?

Interventions in NCT06584019: Range Of Motion applied group.

What condition does NCT06584019 study?

NCT06584019 studies Children With Cancer.

Is NCT06584019 still recruiting?

NCT06584019 is currently completed. Last updated 19 September 2024.

Last reviewed 2024-09-19 · How we verify

NCT06584019

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Range of Motion (ROM) exercıses on Comfort Level and vıtal sıgns

Completed NA Last updated 19 September 2024

What this trial tests

NA trial testing Range Of Motion applied group in Children With Cancer in 30 participants. Completed in 1 July 2024.

Timeline

1 May 2023

Primary endpoint
30 December 2023

1 July 2024

Quick facts

Lead sponsor	Istanbul Medipol University Hospital
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	supportive care
Enrollment	30
Start date	1 May 2023
Primary completion	30 December 2023
Estimated completion	1 July 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Range Of Motion applied group

Conditions studied

Children With Cancer — all drugs for Children With Cancer →

Sponsor

Istanbul Medipol University Hospital

Who can join

Adults 6 to 12, any sex, with Children With Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This experimental study aims to examine the effects of ROM (Range of Motion) exercises on comfort level and vital signs in children diagnosed with cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Istanbul Medipol University Hospital trials

Trials by the same sponsor.

NCT07508371 — Menthol Massage for Post-Bypass Pain & Anxiety · NA · not yet recruiting
NCT07575477 — Comparison Of Early Mobilization And Electrical Stimulation On Functional Recovery After Lumbar Disc Herniation Surgery · NA · not yet recruiting
NCT07525115 — Effects of Proprioceptive Neuromuscular Facilitation-Based Lower Extremity Training on Balance, Gait, and Functional Ind · NA · not yet recruiting
NCT07467278 — Low-FODMAP Diet and Intestinal Permeability in Patients With Irritable Bowel Syndrome · NA · not yet recruiting
NCT07468864 — Validity of the Turkish Situational Vertigo Questionnaire · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06584019 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Istanbul Medipol University Hospital
Last refreshed: 19 September 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06584019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing